Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
SMD Rise PCL's 3-Year RORE % for the quarter that ended in Mar. 2026 was 20.98%.
The industry rank for SMD Rise PCL's 3-Year RORE % or its related term are showing as below:
BKK:SMD100-R's 3-Year RORE % is ranked better than 60.91% of 110
companies
in the Medical Distribution industry
Industry Median: 14.465
vs BKK:SMD100-R: 20.98
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
SMD Rise PCL 3-Year RORE % Related Terms
SMD Rise PCL 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, COR, CAH: 3-Year RORE % Comparison
For the Medical Distribution subindustry, SMD Rise PCL's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL 3-Year RORE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
SMD Rise PCL (BKK:SMD100-R) has a 3-Year RORE % of 20.98 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on SMD Rise PCL and its competitors. According to the industry distribution chart, SMD Rise PCL ranks #43 out of 110 companies in the Medical Distribution industry, placing it in the top 39.1%.
Is SMD Rise PCL's 3-Year RORE % too high?
SMD Rise PCL's current 3-Year RORE % is 20.98. The Medical Distribution industry median 3-Year RORE % is 14.47. SMD Rise PCL's value of 20.98 is 45% above this industry median. Based on the distribution chart, SMD Rise PCL ranks #43 out of 110 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's 3-Year RORE % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #43 out of 110 companies for 3-Year RORE %. This puts SMD Rise PCL in the upper half of its industry. The industry median 3-Year RORE % is 14.47. SMD Rise PCL's value of 20.98 is 45% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Distribution company?
The median 3-Year RORE % among Medical Distribution companies is 14.47, based on 110 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current 3-Year RORE % of 20.98 is 45% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median 3-Year RORE % is 14.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current 3-Year RORE % is 20.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current 3-Year RORE % of 20.98. The stock's GF Value™ is ฿24.66, compared to a current price of ฿5.85 — trading 76.3% below its estimated fair value. The current 3-Year RORE % is 20.98 and 45% above the Medical Distribution industry median of 14.47. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current 3-Year RORE % is 20.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 76.3% below its estimated GF Value™ of ฿24.66.
Key valuation signals for BKK:SMD100-R:
3-Year RORE %: 20.98
GF Value™: ฿24.66 vs. price of ฿5.85 (76.3% below fair value)
Industry Position: 45% above the Medical Distribution median (#43 of 110)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
